8 results match your criteria: "Servicio de Cirugía Ortopédica y Traumatología. Hospital Universitario Germans Trias i Pujol. Badalona[Affiliation]"

Introduction: seizures can trigger fractures and dislocations. Injuries depend on the severity, duration and type of seizure. We present a case report of a male patient who presented with a bilateral central dislocation fracture of the hip following an episode of seizure.

View Article and Find Full Text PDF

Genome sequencing is a very attractive technology as it is also the idea of sequencing children at birth, with the aim to establish medical care and preventive actions during their whole life, tailored to the genome of each newborn. Part I of this article analyses limitations and opportunities of next generation sequencing technologies (NGS). Part II relates scientific knowledge with ethical, legal and social issues (ELSIs) concerning its application to a newborn screening program.

View Article and Find Full Text PDF

In 2003 at the ending of the Human Genome Project, it aroused the idea that all newborns could be sequenced and its genome archived in the clinical record, in order to manage risks of diseases and response to medicaments along his whole life. Eighteen years later, promises of genomic medicine and tremendous decrease of costs of next generation sequencing technologies, continues feeding this dream that shows important practical, ethical and social challenges and genomic sequencing is presented as the next historical change in newborn screening programs. In this paper we analyze challenges and opportunities of next generation sequencing technologies, their real costs, problems associated to management, storage and protection of the enormous amount of genomic data produced and finally, according to conclusions of recent researches, there are considered the conclusions in two contexts, sick newborn with diagnostic purposes and healthy asymptomatic newborns with public health purposes (newborn screening programs).

View Article and Find Full Text PDF

Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice.

AIDS

October 2015

aResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal bSección de Enfermedades Infecciosas, Servicio de Pediatría, Hospital General Universitario 'Gregorio Marañón', Madrid cUnitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona dServicio de Infecciosas Pediátricas, Hospital Universitario 'Doce de Octubre', Madrid eLaboratorio InmunoBiología Molecular, Hospital General Universitario 'Gregorio Marañón', Instituto de Investigación Sanitaria 'Gregrio Marañón' (IiSGM), Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid fUnidad de Estadística y Bioinformática. Institut de Recerca Vall d'Hebron, Barcelona gUnidad Medicina Interna Pediá[Combining Acute Accent]trica, Hospital Infantil Universitario 'Virgen del Rocío', Seville hUnidad Servicio de Pediatría, Hospital Universitario Germans Trias i Pujol Badalona iUnidad de Infectología e Inmunodeficiencias, Servicio de Pediatría, Hospital Regional Universitario 'Carlos Haya', Málaga jUnitat d'Infectologia, Servei de Pediatria; Hospital Sant Joan de Déu, Universitat de Barcelona kPediatric Service, Universitat Autónoma de Barcelona, Hospital del Mar, Barcelona lUnidad de Infectología Pediatrica, Hospital de Cruces, Bilbao mServicio de Enfermedades Infecciosas, Hospital Ramón y Cajal nUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda. Madrid, Spain.

Maraviroc (MVC) is not approved for HIV-1-infected paediatric patients. This is the first assessment of the use of MVC-based salvage therapy in vertically HIV-1-infected paediatric patients in clinical settings. The results suggest that MVC-based salvage therapy is useful in children and adolescents with extensive resistance profile leading to maintained virological suppression in up to 88% of the patients with CCR5-tropic virus.

View Article and Find Full Text PDF

[Abdominal bruit associated with hypertension].

Nefrologia

July 2004

Servicio de Nefrología y Unidad de Hipertensión Arterial, Hospital Universitario Germans Trias i Pujol. Badalona, Barcelona.

First cause of secondary hypertension is renovascular hypertension which presents abdominal bruit in 16 to 20% of cases. This clinical sign is also associated with other vascular disease of the abdomen such as celiac trunk stenosis and/or aneurysms located on the pancreaticoduodenal or gastroduodenal arcs level, with little representation among aneurysm. They usually appear on a context of digestive complications like neoplasias, chronic pancreatitis or gastric obstructions possibly with obstructive icterus, hemorrhage and acute abdomen episodes.

View Article and Find Full Text PDF

Introduction And Objectives: The effect of obesity on cardiac function is still under discussion. The objective of this study was to assess cardiopulmonary capacity in morbidly obese patients. Patients and method.

View Article and Find Full Text PDF

Background: The goal of this study was to determine the prevalence of asbestos-related lung cancer and the importance of the occupational exposure to this inorganic fibre as a risk factor.

Patients And Methods: We performed a cross-sectional study of 82 patients with lung cancer (mean age 62 SD 9 years) and 53 patients without pleuropulmonary disease (63 SD 13 years). The occupational exposure to asbestos was determined by a questionnaire.

View Article and Find Full Text PDF

[Experience with the Du Pen epidural catheter in chronic cancer pain].

Rev Esp Anestesiol Reanim

November 1992

Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Universitario Germans Trias i Pujol. Badalona, Barcelona.

We evaluate the results obtained with the use of Du Pen's epidural catheter in a series of patients with chronic oncologic pain. There were 27 patients with neoplasms of different etiologies who received a total number of 30 catheters. Inclusion criteria were established.

View Article and Find Full Text PDF